Curative effect and prognosis of FOLFOX combined with radiotherapy for locally advanced colorectal cancer

doi:10.3877/cma.j.issn.1674-0793.2016.04.004

Abstract

Abstract:

Objective

To investigate the curative effect of FOLFOX combined with radiotherapy for locally advanced colorectal cancer (T3, T4) and postoperative tumor recurrence and survival rate.

Methods

Clinical data of 125 cases with locally advanced colorectal cancer (T3, T4) in our hospital from June 2008 to May 2012 were retrospectively analyzed. The patients were divided into control group (traditional surgery, 61 cases) and treatment group (radiotherapy+chemotherapy FOLFOX scheme before surgery, 64 cases). The colorectal cancer resection rate, anal anastomosis rate, postoperative complications, tumor recurrence after 3 years, survival rate, and correlation between postoperative recurrence rate were observed.

Results

There were 28 and 45 cases undergoing complete tumor resection in control group and treatment group respectively, with statistical difference between the two groups (P<0.01). Low rectal anastomosis in control group and treatment group were 9 and 19, with significant difference (P=0.04). There was no obvious difference between the two groups in postoperative complications, total accumulative postoperative recurrence, survival rate in 3 years.

Conclusion

FOLFOX chemotherapy combined with radiation therapy can improve tumor resection rate, and anal preservation rate, reduce recurrence rate and increase survival rate in patients with locally advanced colorectal cancer.

Key words: Colorectal neoplasm, Neoadjuvant chemotherapy, FOLFOX, Prognosis, Locally advanced

Honggang Wang, Chunzhong Qiao, Chuanjiang Huang, Yong Wang, Gan Cao, Qinghong Liu. Curative effect and prognosis of FOLFOX combined with radiotherapy for locally advanced colorectal cancer[J]. Chinese Archives of General Surgery(Electronic Edition), 2016, 10(04): 247-250.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhptwkxwx.cma-cmc.com.cn/EN/10.3877/cma.j.issn.1674-0793.2016.04.004

https://zhptwkxwx.cma-cmc.com.cn/EN/Y2016/V10/I04/247

Figures/Tables 3

References 19

1	顾晋,杜敬曾.客观评价和正确开展结直肠癌的新辅助治疗[J].中国实用外科杂志, 2011, 31(1): 47-49.
2	王锡山.结直肠癌综合治疗的规范化实施[J].中国实用外科杂志, 2010, 30(4): 260-264.
3	中华人民共和国卫生和计划生育委员会医政医管局,中华医学会肿瘤学会分会.中国结直肠癌诊疗规范(2015版)[J/CD].中华普通外科学文献:电子版, 2015, 9(6): 506-523.
4	Hompes D,Aalbers A,Boot H, et al. A prospective pilot study to assess neoadjuvant chemotherapy for unresectable peritoneal car-cinomatosis from colorectal cancer[J]. Colorectal Dis, 2014, 16(8): 264-272.
5	Inoue Y,Tanaka R,Komeda K, et al. Fluorescence detection of malignant liver tumors using 5-aminolevulinic acid-mediated photodynamic diagnosis: principles, technique, and clinical expe-rience[J]. World J Surg, 2014, 38(7): 1786-1794.
6	Sclafani F,Gonzalez D,Cunningham D, et al. RAS mutations and cetuximab in locally advanced rectal cancer: results of the EX-PERT-C trial[J]. Eur J Cancer, 2014, 50(8): 1430-1436.
7	Dede K,Salamon F,Landherr L, et al. Pathologic assessment of response to chemotherapy in colorectal cancer liver metastases af-ter hepatic resection: which method to use?[J]. Pathol Oncol Res, 2015, 21(1): 173-179.
8	Cokmert S,Ellidokuz H,Demir L, et al. Survival outcomes of liv-er metastasectomy in colorectal cancer cases: a single-center analysis in Turkey[J]. Asian Pac J Cancer Prev, 2014, 15(13):5195-5200.
9	Landry JC,Feng Y,Cohen SJ, et al. Phase 2 study of preoperative radiation with concurrent capecitabine, oxaliplatin, and bevaci-zumab followed by surgery and postoperative 5-fluorouracil, leu-covorin, oxaliplatin (FOLFOX), and bevacizumab in patients with locally advanced rectal cancer: ECOG 3204[J]. Cancer, 2013, 119(8): 1521-1527.
10	Simpson AL,Leal JN,Pugalenthi A, et al. Chemotherapy-in-duced splenic volume increase is independently associated with major complications after hepatic resection for metastatic colorec-tal cancer[J]. J Am Coll Surg, 2015, 220(3): 271-280.
11	Sutton P,Evans J,Jones R, et al. Proteomic analysis to identify biomarkers in the primary tumour that predict response to neoad-juvant chemotherapy in liver metastases[J]. Lancet, 2015, 385 Suppl 1: S95.
12	赵长林.结直肠癌肝转移转化治疗的相关问题[J/CD].中华普通外科学文献:电子版, 2014, 8(3): 181-184.
13	王林,顾晋.直肠恶性肿瘤的新辅助治疗:研究现状与外科决策[J/CD].中华普通外科学文献:电子版, 2014, 8(6): 176-180.
14	Osada S,Imai H,Sasaki Y, et al. Surgical indications for multiple and synchronous liver metastases from colorectal cancer[J]. Hepatogastroenterology, 2014, 61(131): 722-726.
15	Huang L,Li TJ,Zhang JW, et al. Neoadjuvant chemotherapy followed by surgery versus surgery alone for colorectal cancer: meta-analysis of randomized controlled trials[J]. Medicine (Baltimore), 2014, 93(28): e231.
16	Desurmont T,Skrypek N,Duhamel A, et al. Overexpression of chemokine receptor CXCR2 and ligand CXCL7 in liver metasta-ses from colon cancer is correlated to shorter disease-free and overall survival[J]. Cancer Sci, 2015, 106(3): 262-269.
17	Liu L,Zheng W,Song Y, et al. miRNA-497 Enhances the Sensi-tivity of Colorectal Cancer Cells to Neoadjuvant Chemotherapeu-tic Drug[J]. Curr Protein Pept Sci, 2015,16(4): 310-315.
18	Khan K,Wale A,Brown G, et al. Colorectal cancer with liver me-tastases: neoadjuvant chemotherapy, surgical resection first or pal-liation alone?[J]. World J Gastroenterol, 2014, 20(35): 12391-12406.
19	Elebro J,Heby M,Gaber A, et al. Prognostic and treatment pre-dictive significance of SATB1 and SATB2 expression in pancreat-ic and periampullary adenocarcinoma[J]. J Transl Med, 2014, 12: 289.

组别	例数	年龄（岁， ± s）	性别（例）		肿瘤位置（例）		TNM分期（例）
组别	例数	年龄（岁， ± s）	男	女	结肠	直肠	T3	T4
治疗组	64	62.6±12.4	34	30	28	36	38	26
对照组	61	61.8±11.5	34	27	29	32	38	23
统计值	?	t=0.374	χ²=0.086		χ²=0.181		χ²=0.112
P值	?	0.710	0.769		0.671		0.738

组别	例数	年龄（岁， ± s）	性别（例）		肿瘤位置（例）		TNM分期（例）
组别	例数	年龄（岁， ± s）	男	女	结肠	直肠	T3	T4
治疗组	64	62.6±12.4	34	30	28	36	38	26
对照组	61	61.8±11.5	34	27	29	32	38	23
统计值	?	t=0.374	χ²=0.086		χ²=0.181		χ²=0.112
P值	?	0.710	0.769		0.671		0.738

[1]	Siping Zhang, Wei Liu, Pengcheng Ma. Therapeutic effects of lower extremity mild varus alignment after total knee arthroplasty [J]. Chinese Journal of Joint Surgery(Electronic Edition), 2023, 17(06): 808-817.
[2]	Yuezhou Li, Kongxi Zhang, Xiaohong Li, Zhonghua Shang. Prognostic significance of PUM in gastric carcinoma based on bioinformatics analysis [J]. Chinese Archives of General Surgery(Electronic Edition), 2023, 17(06): 426-432.
[3]	Jun Zhang, Zai Luo, Mingyu Duan, Zhengjun Qiu, Chen Huang. Research progress of prognostic prediction models for gastric cancer [J]. Chinese Archives of General Surgery(Electronic Edition), 2023, 17(06): 456-461.
[4]	Dechen Wang, Kang Yang, Zijie Yang, Mingbin Gui, Lianping Qu, Xiaofeng Zhang, Feng Gao. Progress of microsatellite stability state and PD-1/PD-L1/IDO in colorectal carcinoma [J]. Chinese Archives of General Surgery(Electronic Edition), 2023, 17(06): 462-465.
[5]	Xu Tang, Bing Han, Wei Liu, Ruxing Chen. Analysis of risk factors for metachronous liver metastases after radical colorectal cancer surgery and construction of a predictive model [J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2024, 18(01): 16-20.
[6]	Shengjun Zhang, Ajing Zhao, Shoubo Li, Xianghong Hao, Minli Liu. An experimental study on the promotion of colorectal cancer invasion and migration by high glucose through HGF/c-met pathway [J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2024, 18(01): 21-24.
[7]	Qian Yang, Cuifang Li, Wanqiu Zhang. Analysis of short-term and long-term prognosis and influencing factors of primary liver cancer with spontaneous ruptured hemorrhage after emergency TACE surgery [J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2024, 18(01): 33-36.
[8]	Yansong Li, Huimin Feng, Mingchao Liu, Zepeng Liu, Qiuxia Jiang. Expression and clinical significance of STIP1 in triple negative breast cancer [J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2024, 18(01): 52-56.
[9]	Zhenjian Jiang, Ming Jiang, Dali Huang. The expression and prognostic value of TK1 and Ki67 proteins in differentiated thyroid carcinoma [J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2023, 17(06): 623-626.
[10]	Qingyan Yan, Xiaomei Yong, Hong Luo, Min Du. Prognostic factors and survival analysis of multicenter elderly patients with metastatic breast cancer [J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2023, 17(06): 636-638.
[11]	Xin Lu, Jiayi Xu, Yang Liu, Qin Yang, Wenwen Ju, Yinglong Xu. Comparison of the effects of early LC and PTCD continuous LC on liver function and prognosis of patients with acute cholecystitis [J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2023, 17(06): 648-650.
[12]	Ting Li, Lin Zhang. Relationship between serum fatty acid metabolites and vitamin D levels and colorectal cancer [J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2023, 17(06): 661-665.
[13]	Yongsheng Li, Jiahe Sun, Shuwei Guo, Yikang Lu, Hongzhou Liu. Short-term postoperative complications and their influencing factors in elderly patients with colorectal cancer [J]. Chinese Journal of Clinicians(Electronic Edition), 2023, 17(9): 962-967.
[14]	Jun Wang, Kunpeng Liu, Lan Yao, Hua Zhang, Yue Wei, Libin Suo, Jun Chen, chengli Miao, Chenghua Luo. Retrospective analysis of anesthesia management of massive transfusion patients undergoing retroperitoneal tumor resection [J]. Chinese Journal of Clinicians(Electronic Edition), 2023, 17(08): 844-849.
[15]	Libin Suo, Kunpeng Liu, Lan Yao, Hua Zhang, Yue Wei, Jun Wang, Jun Chen, Chengli Miao, Chenghua Luo. Key points of anesthesia management and prognostic factors in patients undergoing primary retroperitoneal paraganglioma resection [J]. Chinese Journal of Clinicians(Electronic Edition), 2023, 17(07): 771-776.

Please choose a citation manager

Content to export